Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
19 04 2023
Historique:
received: 15 02 2022
revised: 11 08 2022
accepted: 09 09 2022
medline: 21 4 2023
pubmed: 30 9 2022
entrez: 29 9 2022
Statut: ppublish

Résumé

The missense mutation p.R406W in microtubule-associated protein tau leads to frontotemporal lobar degeneration with an amnestic, Alzheimer's disease-like phenotype with an autosomal dominant pattern of inheritance. In 2003, we described the pedigree of a Belgian family, labelled ADG, with 28 p.R406W patients. Over 18 years follow-up, we extended the family with 10 p.R406W carriers and provided an in-depth clinical description of the patients. Additionally, genetic screening was used to identify p.R406W carriers in Belgian cohorts of frontotemporal dementia and Alzheimer's disease patients and to calculate p.R406W frequency. In the frontotemporal dementia cohort, we found four p.R406W carriers (n = 647, 0.62%) and three in the Alzheimer's disease cohort (n = 1134, 0.26%). Haplotype sharing analysis showed evidence of a shared haplotype suggesting that they are descendants of a common ancestor. Of the p.R406W patients, we describe characteristics of neuropsychological, imaging and fluid biomarkers as well as neuropathologic examination. Intriguingly, the phenotypic spectrum among the p.R406W patients ranged from typical behavioural variant frontotemporal dementia to clinical Alzheimer's disease, based on CSF biomarker analysis and amyloid PET scan. Heterogeneous overlap syndromes existed in between, with highly common neuropsychiatric symptoms like disinhibition and aggressiveness, which occurred in 100% of frontotemporal dementia and 58% of clinical Alzheimer's disease patients. This was also the case for memory problems, 89% in frontotemporal dementia and 100% in clinical Alzheimer's disease patients. Median age at death was significantly lower in patients with frontotemporal dementia (68 years) compared to clinical Alzheimer's disease patients (79 years), although the sizes of the sub-cohorts are limited and do not allow prognostic predictions. Post-mortem brain analysis of one p.R406W patient with behavioural variant frontotemporal dementia revealed frontotemporal lobar degeneration with tau pathology. Notably, neuropathological investigation showed only 3R tau isoforms in the absence of 4R tau reactivity, an unusual finding in microtubule-associated protein tau-related frontotemporal lobar degeneration. No traces of amyloid pathology were present. Prevalence of the p.R406W mutation was relatively high in both frontotemporal dementia and Alzheimer's disease Belgian patient cohorts. These findings grant new insights into genotype-phenotype correlations of p.R406W carriers. They may help in further unravelling of the pathophysiology of this tauopathy and in facilitating the identification of patients with p.R406W-related frontotemporal lobar degeneration, both in clinical diagnostic and research settings.

Identifiants

pubmed: 36171642
pii: 6726805
doi: 10.1093/brain/awac362
pmc: PMC10115352
doi:

Substances chimiques

tau Proteins 0
Biomarkers 0
MAPT protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1624-1636

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Acta Neurol Scand. 2002 Apr;105(4):261-9
pubmed: 11939938
Neuropathol Appl Neurobiol. 2015 Feb;41(1):24-46
pubmed: 25556536
J Alzheimers Dis. 2006;9(3 Suppl):417-23
pubmed: 16914880
Parkinsonism Relat Disord. 2014 Sep;20(9):957-64
pubmed: 24998994
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):267-75
pubmed: 22545037
Ann Neurol. 1997 Oct;42(4):564-72
pubmed: 9382467
J Neurochem. 2016 Aug;138 Suppl 1:54-70
pubmed: 27306735
Ann N Y Acad Sci. 2000;920:115-9
pubmed: 11193139
Brain. 2003 Sep;126(Pt 9):2016-22
pubmed: 12876142
Ann Neurol. 1998 Jun;43(6):815-25
pubmed: 9629852
Brain. 2018 Feb 1;141(2):521-534
pubmed: 29253099
Parkinsonism Relat Disord. 2015 Aug;21(8):1002-4
pubmed: 26028272
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Ann Clin Transl Neurol. 2021 Jan;8(1):95-110
pubmed: 33247623
Lab Invest. 2019 Jul;99(7):912-928
pubmed: 30742061
Neurology. 2012 Apr 3;78(14):1043-50
pubmed: 22377814
Neuropathology. 2015 Feb;35(1):75-82
pubmed: 25377499
J Neurol. 2019 Aug;266(8):2075-2086
pubmed: 31119452
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Prog Mol Biol Transl Sci. 2012;107:263-93
pubmed: 22482453
Dement Geriatr Cogn Disord. 2008;26(1):43-9
pubmed: 18587238
Neurology. 2021 Aug 31;97(9):e941-e952
pubmed: 34158384
Neuropathol Appl Neurobiol. 2016 Apr;42(3):291-5
pubmed: 25942996
Brain Res Bull. 2016 Sep;126(Pt 3):238-292
pubmed: 27615390
Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23
pubmed: 25495175
J Alzheimers Dis. 2014;41(3):819-33
pubmed: 24685637
Hum Mutat. 2003 Nov;22(5):409-11
pubmed: 14517953
Parkinsonism Relat Disord. 2021 Sep;90:142-154
pubmed: 34593302
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7737-41
pubmed: 9636220
Neurobiol Dis. 2017 Sep;105:74-83
pubmed: 28502805
Neurology. 2018 Mar 13;90(11):e947-e954
pubmed: 29440563
Alzheimers Dement. 2014 May;10(3):360-5
pubmed: 23727082
Dement Geriatr Cogn Disord. 2004;17(4):298-301
pubmed: 15178940
Alzheimers Res Ther. 2018 Jan 9;10(1):2
pubmed: 29370822
Ann Clin Transl Neurol. 2021 Sep;8(9):1817-1830
pubmed: 34342183
Am J Hum Genet. 1999 Feb;64(2):414-21
pubmed: 9973279
Brain. 2016 Nov 1;139(11):2957-2969
pubmed: 27591113
Acta Neuropathol. 2012 Sep;124(3):353-72
pubmed: 22890575
J Alzheimers Dis. 2016 Aug 10;54(1):383-95
pubmed: 27567807
Acta Neuropathol. 2011 Jul;122(1):111-3
pubmed: 21644037
Ann Neurol. 1999 Oct;46(4):617-26
pubmed: 10514099
Nature. 1998 Jun 18;393(6686):702-5
pubmed: 9641683
Gene. 2015 Oct 1;570(1):150-2
pubmed: 26086902
Alzheimers Res Ther. 2018 Jan 22;10(1):7
pubmed: 29370838
Dement Geriatr Cogn Disord. 2004;17(4):287-92
pubmed: 15178938
Eur J Neurol. 2008 Apr;15(4):377-85
pubmed: 18284428
Neurology. 2002 Mar 12;58(5):811-3
pubmed: 11889249
Ann Clin Transl Neurol. 2015 Nov 12;2(12):1124-8
pubmed: 26734663
Am J Pathol. 2001 Feb;158(2):373-9
pubmed: 11159174
J Alzheimers Dis. 2010;22(4):1313-29
pubmed: 20930284
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Neuropathol Exp Neurol. 2005 May;64(5):420-8
pubmed: 15892300

Auteurs

Helena Gossye (H)

VIB Center for Molecular Neurology, 2610 Antwerp, Belgium.
Department of Neurology, University Hospital Antwerp, 2650 Edegem, Belgium.
Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Sara Van Mossevelde (S)

Department of Neurology, University Hospital Antwerp, 2650 Edegem, Belgium.
Institute Born-Bunge, 2610 Antwerp, Belgium.
Department of Neurology and Memory Clinic, Hospital Network Antwerp, 2000 Antwerp, Belgium.
Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Anne Sieben (A)

Institute Born-Bunge, 2610 Antwerp, Belgium.
Department of Anatomopathology, University Hospital Antwerp, 2650 Edegem, Belgium.

Maria Bjerke (M)

Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Department of Clinical Chemistry, Universitair Ziekenhuis Brussel and Center for Neurosciences, Vrije Universiteit Brussel, 1000 Brussel, Belgium.

Elisabeth Hendrickx Van de Craen (E)

VIB Center for Molecular Neurology, 2610 Antwerp, Belgium.
Department of Neurology, University Hospital Antwerp, 2650 Edegem, Belgium.
Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Julie van der Zee (J)

VIB Center for Molecular Neurology, 2610 Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Peter P De Deyn (PP)

Institute Born-Bunge, 2610 Antwerp, Belgium.
Department of Neurology and Alzheimer Center, University of Groningen, 9713 Groningen, The Netherlands.

Jan De Bleecker (J)

Department of Neurology, University Hospital Ghent, 9000 Gent, Belgium.

Jan Versijpt (J)

Department of Neurology, Universitair Ziekenhuis Brussel and Center for Neurosciences, Vrije Universiteit Brussel, 1000 Brussel, Belgium.

Jenneke van den Ende (J)

Department of Medical Genetics, University Hospital Antwerp, 2650 Edegem, Belgium.

Olivier Deryck (O)

Department of Neurology, General Hospital Sint-Jan, 8000 Brugge, Belgium.

Paul Bourgeois (P)

Department of Neurology, General Hospital Groeninge, 8500 Kortrijk, Belgium.

Jean-Christophe Bier (JC)

Department of Neurology, Erasmus Hospital, University Clinics of Brussels, 1000 Brussel, Belgium.

Maarten Goethals (M)

Department of Neurology, General Hospital Delta, 8800 Roeselare, Belgium.

Rik Vandenberghe (R)

Laboratory for Cognitive Neurology, Department of Neurosciences, University Hospital and University of Leuven, 3000 Leuven, Belgium.
Neurology Service, University Hospitals Leuven, 3000 Leuven, Belgium.

Sebastiaan Engelborghs (S)

Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Department of Neurology, Universitair Ziekenhuis Brussel and Center for Neurosciences, Vrije Universiteit Brussel, 1000 Brussel, Belgium.

Christine Van Broeckhoven (C)

VIB Center for Molecular Neurology, 2610 Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH